-
公开(公告)号：US08841264B2
公开(公告)日：2014-09-23
申请号：US12373584
申请日：2007-07-12
IPC分类号： A01N43/04 , A61K31/70 , A01N43/16 , A61K31/35 , A01N31/08 , A61K31/05 , A01N31/00 , A61K31/045 , A01N29/00 , A61K31/01 , C07H13/02 , A61K31/343 , A61K31/366
CPC分类号： A61K31/343 , A61K31/05 , A61K31/366 , A61K2300/00
摘要： Compositions containing a combination of hydroxytyrosol and resveratrol or liqustilide or (−)-epigallocatechin gallate or honokiol or genistein or Magnolia bark extract or a combination of oleuropein and resveratrol or ligustilide are used to treat inflammatory disorders.
摘要翻译： 含有羟基酪醇和白藜芦醇或苯磺酰肼或（ - ） - 表没食子儿茶素没食子酸酯或和厚朴酚或染料木素或木兰树皮提取物或橄榄苦蛋白和白藜芦醇或琉璃酰苯的组合的组合物用于治疗炎症性疾病。
-
2.发明申请NOVEL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS. 审中-公开新的组合物及其用于治疗，并发治疗或预防炎性疾病的组合物。公开(公告)号：US20110014308A1
公开(公告)日：2011-01-20
申请号：US12747368
申请日：2008-12-11
CPC分类号： A61K31/726 , A61K31/05 , A61K31/737 , A61K36/63 , A61K2300/00
摘要： The present invention relates to novel compositions comprising hydroxytyrosol and chondroitin as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译： 本发明涉及包含羟基酪醇和软骨素的新型组合物以及这些组合物作为药物，特别是作为治疗，共同治疗或预防炎症性疾病的药物的用途。
-
公开(公告)号：US20100056463A1
公开(公告)日：2010-03-04
申请号：US12373584
申请日：2007-07-12
IPC分类号： A61K31/7004 , A61K31/05
CPC分类号： A61K31/343 , A61K31/05 , A61K31/366 , A61K2300/00
摘要： The present invention relates to novel compositions comprising hydroxytyrosol and/or oleuropein (I) and at least one additional component e.g. selected from the group of ligustilide, oleuropein aglycone, magnolol, honokiol, genistein, resveratrol, EGCG, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译： 本发明涉及包含羟基酪醇和/或橄榄苦蛋白（I）和至少一种另外的组分的新型组合物， 选自ligustilide，橄榄苦苷苷，厚朴酚，和厚朴酚，染料木素，白藜芦醇，EGCG，木兰树皮提取物，腰果提取物和甘草，以及这些组合物作为药物的用途，特别是作为药物的用途 治疗，共同治疗或预防炎症性疾病。
-
公开(公告)号：US20100055218A1
公开(公告)日：2010-03-04
申请号：US12373617
申请日：2007-07-12
IPC分类号： A61K36/73
CPC分类号： A61K36/484 , A23L33/105 , A23V2002/00 , A61K31/635 , A61K36/185 , A61K36/23 , A61K36/575 , A61K36/738 , A61K36/76 , A61K36/77 , A61K45/06 , A61K2300/00 , A23V2200/324 , A23V2250/21
摘要： The present invention relates to novel compositions comprising rosehip and at least one additional component e.g. selected from ligustilide, oleuropein (I), oleuropein aglycone (II), hydroxytyrosol, genistein, magnolol, honokiol, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译： 本发明涉及包含玫瑰果和至少一种另外的组分的新型组合物，例如 选自ligustilide，oleuropein（I），oleuropein糖苷配基（II），羟基酪醇，染料木素，厚朴酚，厚朴酚，木兰树皮提取物，腰果提取物和甘草，以及这些组合物作为药物的用途，特别是作为 用于治疗，共同治疗或预防炎症性疾病的药物。
-
5.发明申请公开(公告)号：US20130005682A1
公开(公告)日：2013-01-03
申请号：US13616643
申请日：2012-09-14
IPC分类号： A61K31/05 , A61P19/04 , A61P19/02 , A61K31/737
CPC分类号： A61K31/05 , A61K31/202 , A61K31/7004 , A61K31/737 , A61K2300/00
摘要： The invention relates to the use of hydroxytyrosol for inducing or enhancing cartilage repair or cartilage regeneration. Furthermore, the invention relates to nutraceutical and pharmaceutical compositions comprising hydroxytyrosol for regeneration and repair of cartilage injuries in joints, in particular of traumatic cartilage injuries.
摘要翻译： 本发明涉及羟基酪醇诱导或增强软骨修复或软骨再生的用途。 此外，本发明涉及包含用于再生和修复关节软骨损伤的羟基酪醇，特别是创伤性软骨损伤的营养药物和药物组合物。
-
公开(公告)号：US20100113611A1
公开(公告)日：2010-05-06
申请号：US12596228
申请日：2008-04-03
CPC分类号： A61K31/05 , A61K31/202 , A61K31/7004 , A61K31/737 , A61K2300/00
摘要： The invention relates to the use of hydroxytyrosol for inducing or enhancing cartilage repair or cartilage regeneration. Furthermore, the invention relates to nutraceutical and pharmaceutical compositions comprising hydroxytyrosol for regeneration and repair of cartilage injuries in joints, in particular of traumatic cartilage injuries.
摘要翻译： 本发明涉及羟基酪醇诱导或增强软骨修复或软骨再生的用途。 此外，本发明涉及包含用于再生和修复关节软骨损伤的羟基酪醇，特别是创伤性软骨损伤的营养药物和药物组合物。
-
公开(公告)号：US20110300240A1
公开(公告)日：2011-12-08
申请号：US13202154
申请日：2010-02-19
CPC分类号： A61K31/7008 , A61K36/48 , A61K2300/00
摘要： The present invention relates to novel compositions comprising Cajanus and glucosamine as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
摘要翻译： 本发明涉及包含Cajanus和葡糖胺的新型组合物以及这些组合物作为药物，特别是作为治疗，共同治疗或预防炎症性疾病的药物的用途。
-
公开(公告)号：US20090298933A1
公开(公告)日：2009-12-03
申请号：US12520646
申请日：2007-12-13
申请人： Regina Goralczyk , Joseph Schwager , Karin Wertz
发明人： Regina Goralczyk , Joseph Schwager , Karin Wertz
IPC分类号： A61K31/352
摘要： Composition containing the combination of (−)-epigallocatechin gallate (EGCG) and lycopene characterized in that the ratio of EGCG to lycopene is in the range of 100:1 to 1:1.
摘要翻译： 包含（ - ） - 表没食子儿茶素没食子酸酯（EGCG）和番茄红素的组合的组合物，其特征在于EGCG与番茄红素的比例在100:1至1:1的范围内。
-
公开(公告)号：US20120052141A1
公开(公告)日：2012-03-01
申请号：US13289128
申请日：2011-11-04
申请人： Regina GORALCZYK , Joseph Schwager , Karin Wertz
发明人： Regina GORALCZYK , Joseph Schwager , Karin Wertz
IPC分类号： A61K8/97 , A61K31/353 , A61K8/49 , A61K31/05 , A61K8/34 , A61K31/202 , A61K8/36 , A61K31/01 , A61K8/31 , A61K31/045 , A61K31/047 , A61K31/352 , A61Q19/06 , A61P17/00 , C07D311/62 , C07C39/21 , C07C39/11 , C07C35/21 , C07C11/21 , A61K36/738
CPC分类号： A61K8/31 , A21D2/36 , A23C9/13 , A23C9/1322 , A23L33/30 , A61K8/345 , A61K8/347 , A61K8/361 , A61K8/498 , A61K8/97 , A61K2800/92 , A61Q19/06
摘要： The present invention is directed inter alia to the use of at least one compound selected from the group consisting of (−)-epigallocatechin gallate, resveratrol, eicosapentaenoic acid, docosahexaenoic acid, rose hip extract/concentrate, hydroxytyrosol, lycopene, lutein, β-cryptoxanthin, zeaxanthin and derivatives thereof, for the treatment of cellulite, for the prevention of the development of mild cellulite, for the prevention of the progression of mild cellulite to severe cellulite, for smoothening the micro relief of the skin, for maintaining or increasing the tensile properties of the skin, and/or for reducing the fat mass and the circumference at the hips and thighs, as well as to the corresponding cosmetic and medical methods.
摘要翻译： 本发明特别涉及使用至少一种选自（ - ） - 表没食子儿茶素没食子酸酯，白藜芦醇，二十碳五烯酸，二十二碳六烯酸，玫瑰果提取物/浓缩物，羟基酪醇，番茄红素，叶黄素， 玉米黄质及其衍生物，用于治疗脂肪团，用于防止轻度脂肪团的发育，以防止轻度脂肪团进入严重脂肪团，使平滑肌肤的微小浮雕，维持或增加 皮肤的拉伸性能和/或用于降低臀部和大腿处的脂肪量和周长，以及相应的化妆品和医疗方法。
-
10.发明申请NOVEL USE OF COMPOUNDS AND COMBINATIONS OF COMPOUNDS FOR IMPROVING THE PHYSICAL APPEARANCE 审中-公开化合物的新用途和化合物的组合改善物理外观公开(公告)号：US20100015262A1
公开(公告)日：2010-01-21
申请号：US12295408
申请日：2007-04-02
申请人： Regina Goralczyk , Joseph Schwager , Karin Wertz
发明人： Regina Goralczyk , Joseph Schwager , Karin Wertz
IPC分类号： A61K36/73 , A61K31/352 , A61K31/047 , A61K31/20 , A61K31/05 , A61K31/197 , A61P17/00 , A61P3/00
CPC分类号： A61K8/31 , A21D2/36 , A23C9/13 , A23C9/1322 , A23L33/30 , A61K8/345 , A61K8/347 , A61K8/361 , A61K8/498 , A61K8/97 , A61K2800/92 , A61Q19/06
摘要： The present invention is directed inter alia to the use of at least one compound selected from the group consisting of (−)-epigallocatechin gallate, resveratrol, eicosapentaenoic acid, docosahexaenioic acid, rose hip extract/concentrate, hydroxytyrosol, lycopene, lutein, β-cryptoxanthin, zeaxanithin and derivatives thereof, for the treatment of cellulite, for the prevention of the development of mild cellulite, for the prevention of the progression of mild cellulite to severe cellulite, for smoothening the micro relief of the skin, for maintaining or increasing the tensile properties of the skin, and/or for reducing the fat mass and the circumference at the hips and thighs, as well as to the corresponding cosmetic and medical methods.
摘要翻译： 本发明特别涉及使用至少一种选自（ - ） - 表没食子儿茶素没食子酸酯，白藜芦醇，二十碳五烯酸，二十二碳六烯酸，玫瑰果提取物/浓缩物，羟基酪醇，番茄红素，叶黄素，β- 隐黄质，玉米黄素及其衍生物，用于治疗脂肪团，用于防止轻度脂肪团的发育，用于防止轻度脂肪团进入严重脂肪团的进展，以平滑皮肤的微小浮雕，维持或增加 皮肤的拉伸性能和/或用于降低臀部和大腿处的脂肪量和周长，以及相应的美容和医疗方法。
-
-
-
-
-
-
-
-
-
搜索结果
23 条记录 (耗时 0.024 秒)
